Thrombocytopenic purpura
MONDO:0043768Purpura associated with a reduction in circulating blood platelets which can result from a variety of factors.
Also known as: thrombocytopenic purpura, purpura, thrombopenic, purpuras, thrombocytopenic, purpuras, thrombopenic, thrombocytopenic purpuras, thrombopenic purpura, thrombopenic purpuras
128 clinical trials for this condition and its sub-types, 8 tagged with Thrombocytopenic purpura itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Thrombocytopenic purpura
-
Autoimmune thrombocytopenic purpura 95 trials
-
Thrombotic thrombocytopenic purpura 15 trials · 20 incl. sub-types
2 sub-types
-
New hope for bleeding risk in hepatitis b patients?
Disease control CompletedThis study tested the drug eltrombopag in 48 Chinese adults with chronic hepatitis B and a bleeding disorder called immune thrombocytopenia (low platelets). The goal was to see if taking eltrombopag for 6 to 22 weeks could safely raise platelet counts. The trial is complete, but …
Phase 2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New tests could help spot hidden blood disorder in seniors
Knowledge-focused CompletedThis study followed 37 adults over age 60 with unexplained low platelet counts to see if certain tests could predict immune thrombocytopenic purpura (ITP). Participants had blood tests, bone marrow biopsies, and a short course of the steroid prednisone. The goal was to find which…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Tiny study asks: does aspirin work in patients with low platelets?
Knowledge-focused CompletedThis study looked at how well a daily low-dose aspirin works in people who have both immune thrombocytopenia (low platelets) and heart disease. Only 4 adults took part. Researchers measured platelet function after aspirin to see if the standard dose is enough to prevent blood clo…
Phase 2 • Sponsor: University Hospital, Toulouse • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC